Gregory Norden

Gregory Norden, listed as board member, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Zoetis Inc., NanoString Technologies Inc and Royalty Pharma plc. Over a trading history stretching from 27 February 2018 to 14 May 2026, the count stands at 53 filings.

On the open market, the record shows 1 purchase worth €115k and 6 sales worth €2.9M. The net balance comes to €2.7M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 8 share grants and 18 option exercises. Since January 2026: no purchases and 1 sale on the market.

The latest filing, published on 15 May 2026, reports an open-market sale of €138k in Royalty Pharma plc. The latest purchase dates back some time: it was published 1,326 days ago, on 8 March 2023. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.